Barclays Maintains Overweight on Intuitive Surgical, Raises Price Target to $510
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Matt Miksic maintains an Overweight rating on Intuitive Surgical (NASDAQ:ISRG) and raises the price target from $490 to $510.
July 23, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Matt Miksic maintains an Overweight rating on Intuitive Surgical and raises the price target from $490 to $510.
The raised price target and maintained Overweight rating from a reputable analyst at Barclays is likely to positively impact investor sentiment and drive short-term price appreciation for ISRG.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100